UN High Level Meeting Debates TRIPS Flexibilities for Non Communicable Diseases
On September 19-20, the UN held a High Level Meeting to develop a global strategy to fight Non-Communicable Diseases (NCDs), “principally cardiovascular diseases, cancers, chronic respiratory diseases...
View ArticleBayer Asked to Disclose R&D Cost Data for Anticancer Drug
The Indian pharmaceutical company Natco has applied for a compulsory license for sorafenib, an anticancer drug sold by Bayer under the brand name Nexavar. The price charged by Bayer is Rs 2,80,428 per...
View ArticleIndia Issues Compulsory License for Anticancer Medicine
India has granted Natco Pharma Ltd. a compulsory license to produce generic sorafenib tosylate – a drug used to treat kidney and liver cancer that is patented by Bayer and sold under the brand name...
View ArticleGTPI supports judicial decision annulling patent HIV / AIDS medicine
Below is the Statement of the Grupo de Trabalho Sobre, Propriedade Intelectual on the Brazlian government’s decision to annul Abbott Laboratories’ patent on lopinavir+ritonavir, an important...
View ArticleUSPTO Official Misleads Congress on Permissible Scope of Compulsory Licenses...
In testimony before the U.S. House of Representatives Subcommittee on Intellectual Property, Competition and the Internet on 27 June 2012 (Hearing: Protecting Patents, Trade Secrets, and Market...
View ArticleCompulsory License for Anti-Cancer Drugs – Update from Campaign for...
Press Release by the Campaign for Affordable Trastuzumab CONTACT: Kalyani Menon-Sen: +91 9910306382, kmenonsen[at] gmail.com Leena Menghaney: +91 9811365412, leenamenghaney [at] gmail.com The Campaign...
View ArticlePatients and Parliamentarians ask Chilean President Michelle Bachelet to...
Representatives of Corporacion Innovarte, Patient Foundation Nuevo Renacer, Pharmaceutical Chemists Guild, and cancer and hepatitis patients attended the Presidential Palace “La Moneda” on November...
View Article
